30 day notice

53112

Federal Register / Vol. 89, No. 122 / Tuesday, June 25, 2024 / Notices

HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.

Dated: June 18, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–13838 Filed 6–24–24; 8:45 am]

Maria G. Button,
Director, Executive Secretariat.

BILLING CODE 4140–01–P

[FR Doc. 2024–13857 Filed 6–24–24; 8:45 am]

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

BILLING CODE 4165–15–P

National Institutes of Health

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

khammond on DSKJM1Z7X2PROD with NOTICES

Fishers Lane, Room 3G21A, Rockville, MD
20852, 240.627.3219, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)

Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: July 18, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G21A,
Rockville, MD 20852 (Video Assisted
Meeting).
Contact Person: Shiv A. Prasad, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601

VerDate Sep<11>2014

17:03 Jun 24, 2024

Jkt 262001

Submission for OMB Review; 30-Day
Comment Request Generic Clearance
for the Collection of Qualitative
Feedback on Agency Service Delivery
(NIH)
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:

Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Ms. Mikia Currie,
Project Clearance Officer, Office of
Policy for Extramural Research
Administration, 6705 Rockledge Drive,
Suite 350, Bethesda, Maryland 20892 or
call non-toll-free number (301) 435–
ADDRESSES:

PO 00000

Frm 00075

Fmt 4703

Sfmt 4703

0941 or email your request, including
your address to: [email protected].
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on April 10th, 2024 (89 FR
25275) and allowed 60 days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment.
The National Institutes of Health
(NIH) may not conduct or sponsor, and
the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a currently valid
Office of Management and Budget
(OMB) control number.
In compliance with section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, NIH has
submitted to OMB a request for review
and approval of the information
collection listed below.
Proposed Collection: Generic
Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery, EXTENSION, 0925–0648,
expiration date 06/30/2024, National
Institutes of Health (NIH).
Need and Use of Information
Collection: There are no substantive
changes being requested for this
submission. The information collection
activity will garner qualitative customer
and stakeholder feedback in an efficient,
timely manner, in accordance with the
Administration’s commitment to
improving service delivery. This generic
clearance will continue to provide
information about the NIH Institutes
and Centers customer or stakeholder
perceptions, experiences, and
expectations, provide an early warning
of issues with service, or focus attention
on areas where communication,
training, or changes in operations might
improve delivery of products or
services. It will also allow feedback to
contribute directly to the improvement
of program management. Feedback
collected under this generic clearance
will provide useful information, but it
will not yield data that can be
generalized to the overall population.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
103,083.

E:\FR\FM\25JNN1.SGM

25JNN1

53113

Federal Register / Vol. 89, No. 122 / Tuesday, June 25, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of collection

Average time
per response
(in hours)

Total annual
burden hours

Customer Satisfaction Surveys .......................................................................
In-Depth Interviews (IDIs) or Small Discussion Groups ..................................
Focus Groups ..................................................................................................
Usability and Pilot Testing ...............................................................................
Conference/Training—Pre-and Post-Surveys ..................................................
NIH-Wide Basic Abstract Form ........................................................................
NIH-Wide Basic Registration Form ..................................................................

1,000
1,000
1,000
150,000
100,000
50,000
75,000

1
1
1
1
2
1
1

30/60
90/60
90/60
5/60
10/60
1
3/60

500
1,500
1,500
12,500
33,333
50,000
3,750

Total ..........................................................................................................

378,000

478,000

........................

103,083

Dated: June 17, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2024–13914 Filed 6–24–24; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel; Review
of AREA grants in Cell Biology,
Molecular Biology and Genetics, July
08, 2024, 09:00 a.m. to July 09, 2024,
07:00 p.m., National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, which was
published in the Federal Register on
June 07, 2024, 89 FR 48659, Doc 2024–
12475.
This meeting is being amended to
change the meeting from a two-day
meeting to a one-day meeting on July 8,
2024, from 9:00 a.m. to 7:00 p.m. The
meeting is closed to the public.
Dated: June 18, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–13840 Filed 6–24–24; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES

Annual
frequency
per response

National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.

VerDate Sep<11>2014

17:03 Jun 24, 2024

Jkt 262001

The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Social and Community Influences
Across the Lifecourse.
Date: July 15–16, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Hybrid Meeting).
Contact Person: David E Pollio, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006F,
Bethesda, MD 20892, (301) 594–4002,
[email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Microbial Diagnostics, Detection
and Decontamination.
Date: July 17–18, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Shinako Takada, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–827–5997, shinako.takada@
nih.gov.
Name of Committee: Social and
Community Influences on Health Integrated
Review Group; Population and Public Health
Approaches to HIV/AIDS Study Section.
Date: July 17–18, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.

PO 00000

Frm 00076

Fmt 4703

Sfmt 4703

Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aubrey S Madkour, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000C,
Bethesda, MD 20892, (301) 594–6891,
[email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA:
Understanding Neurological Effects of
COVID–19 and Post-Acute Sequelae of
SARS–CoV–2 Infection.
Date: July 17–18, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aleksey Gregory
Kazantsev, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 5201, Bethesda, MD 20892, (301) 435–
1042, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cancer
Diagnostics and Treatments (CDT).
Date: July 17–18, 2024.
Time: 9:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victor A Panchenko,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 802B2,
Bethesda, MD 20892, (301) 867–5309,
[email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Clinical Care and Health
Interventions.
Date: July 17, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacinta Bronte-Tinkew,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164,

E:\FR\FM\25JNN1.SGM

25JNN1